AIDS 0 4 0 4 B-chronic_disease
defined 5 12 5 12 O
as 13 15 13 15 O
a 16 17 16 17 O
CD4 18 21 18 21 B-clinical_variable
( 22 23 22 23 I-clinical_variable
cluster 23 30 23 30 I-clinical_variable
of 31 33 31 33 I-clinical_variable
differentiation 34 49 34 49 I-clinical_variable
4 50 51 50 51 I-clinical_variable
) 51 52 51 52 I-clinical_variable
count 53 58 53 58 I-clinical_variable
less 59 63 59 63 O
then 64 68 64 68 O
200 69 72 69 72 B-upper_bound
in 73 75 73 75 O
the 76 79 76 79 O
context 80 87 80 87 O
of 88 90 88 90 O
HIV 91 94 91 94 B-chronic_disease
sero 95 99 95 99 O
- 99 100 99 100 O
positivity 100 110 100 110 O
or 111 113 111 113 O
chronically 114 125 114 125 O
is 126 128 126 128 O
taking 129 135 129 135 O
immunosuppressive 136 153 136 153 B-treatment
medication 154 164 154 164 I-treatment
such 165 169 165 169 O
as 170 172 170 172 O
steroids 173 181 173 181 B-treatment
or 182 184 182 184 O
transplant 185 195 185 195 B-treatment
related 196 203 196 203 I-treatment
medications 204 215 204 215 I-treatment

Absolute 0 8 216 224 B-clinical_variable
neutrophil 9 19 225 235 I-clinical_variable
count 20 25 236 241 I-clinical_variable
> 26 27 242 243 O
1000 28 32 244 248 B-lower_bound
/ 32 33 248 249 I-lower_bound
mm3 33 36 249 252 I-lower_bound

All 0 3 253 256 O
other 4 9 257 262 O
patients 10 18 263 271 O
must 19 23 272 276 O
be 24 26 277 279 O
18 27 29 280 282 B-lower_bound
years 30 35 283 288 I-lower_bound
of 36 38 289 291 O
age 39 42 292 295 B-age
or 43 45 296 298 O
older 46 51 299 304 O

At 0 2 305 307 O
least 3 8 308 313 O
one 9 12 314 317 B-lower_bound
accessible 13 23 318 328 O
primary 24 31 329 336 B-cancer
or 32 34 337 339 I-cancer
metastatic 35 45 340 350 I-cancer
tumor 46 51 351 356 I-cancer
site 52 56 357 361 O
that 57 61 362 366 O
can 62 65 367 370 O
be 66 68 371 373 O
readily 69 76 374 381 O
injected 77 85 382 390 O
IT 86 88 391 393 O
with 89 93 394 398 O
poly 94 98 399 403 B-treatment
- 98 99 403 404 I-treatment
ICLC 99 103 404 408 I-treatment
with 104 108 409 413 O
or 109 111 414 416 O
without 112 119 417 424 O
ultrasound 120 130 425 435 O
guidance 131 139 436 444 O

Bulky 0 5 445 450 B-cancer
intracranial 6 18 451 463 I-cancer
metastatic 19 29 464 474 I-cancer
disease 30 37 475 482 I-cancer
with 38 42 483 487 O
shift 43 48 488 493 O
of 49 51 494 496 O
midline 52 59 497 504 O
structures 60 70 505 515 O
or 71 73 516 518 O
progressive 74 85 519 530 O
brain 86 91 531 536 B-cancer
metastasis 92 102 537 547 I-cancer
such 103 107 548 552 O
that 108 112 553 557 O
ongoing 113 120 558 565 O
therapy 121 128 566 573 B-treatment
for 129 132 574 577 O
these 133 138 578 583 O
brain 139 144 584 589 O
metastasis 145 155 590 600 O
is 156 158 601 603 O
required 159 167 604 612 O
at 168 170 613 615 O
the 171 174 616 619 O
time 175 179 620 624 O
of 180 182 625 627 O
enrollment 183 193 628 638 O

Contraception 0 13 639 652 O
must 14 18 653 657 O
be 19 21 658 660 O
continued 22 31 661 670 O
for 32 35 671 674 O
at 36 38 675 677 O
least 39 44 678 683 O
2 45 46 684 685 B-lower_bound
months 47 53 686 692 I-lower_bound
following 54 63 693 702 O
the 64 67 703 706 O
last 68 72 707 711 O
dose 73 77 712 716 O
of 78 80 717 719 O
poly 81 85 720 724 B-treatment
- 85 86 724 725 I-treatment
ICLC 86 90 725 729 I-treatment

Creatinine 0 10 730 740 B-clinical_variable
≤ 11 12 741 742 O
2.5 13 16 743 746 B-upper_bound
mg 17 19 747 749 I-upper_bound
/ 19 20 749 750 I-upper_bound
dl 20 22 750 752 I-upper_bound

Eastern 0 7 753 760 B-clinical_variable
Cooperative 8 19 761 772 I-clinical_variable
Oncology 20 28 773 781 I-clinical_variable
Group 29 34 782 787 I-clinical_variable
( 35 36 788 789 I-clinical_variable
ECOG 36 40 789 793 I-clinical_variable
) 40 41 793 794 I-clinical_variable
performance 42 53 795 806 I-clinical_variable
status 54 60 807 813 I-clinical_variable
of 61 63 814 816 O
≤ 64 65 817 818 O
2 66 67 819 820 B-upper_bound

Head 0 4 821 825 B-cancer
and 5 8 826 829 I-cancer
neck 9 13 830 834 I-cancer
cancer 14 20 835 841 I-cancer
patients 21 29 842 850 O
with 30 34 851 855 O
tumor 35 40 856 861 B-cancer
invading 41 49 862 870 O
major 50 55 871 876 O
blood 56 61 877 882 O
vessels 62 69 883 890 O
for 70 73 891 894 O
whom 74 78 895 899 O
there 79 84 900 905 O
may 85 88 906 909 O
be 89 91 910 912 O
a 92 93 913 914 O
risk 94 98 915 919 O
of 99 101 920 922 O
blockage 102 110 923 931 O
or 111 113 932 934 O
bleeding 114 122 935 943 O
if 123 125 944 946 O
inflammation 126 138 947 959 O
or 139 141 960 962 O
edema 142 147 963 968 B-chronic_disease
is 148 150 969 971 O
transiently 151 162 972 983 O
increased 163 172 984 993 O
by 173 175 994 996 O
Hiltonol 176 184 997 1005 B-treatment
injections 185 195 1006 1016 I-treatment

History 0 7 1017 1024 O
of 8 10 1025 1027 O
active 11 17 1028 1034 B-treatment
immunotherapy 18 31 1035 1048 I-treatment
in 32 34 1049 1051 O
the 35 38 1052 1055 O
previous 39 47 1056 1064 O
month 48 53 1065 1070 O

In 0 2 1071 1073 O
the 3 6 1074 1077 O
opinion 7 14 1078 1085 O
of 15 17 1086 1088 O
the 18 21 1089 1092 O
local 22 27 1093 1098 O
PI 28 30 1099 1101 O
: 30 31 1101 1102 O
Head 32 36 1103 1107 B-cancer
and 37 40 1108 1111 I-cancer
neck 41 45 1112 1116 I-cancer
cancer 46 52 1117 1123 I-cancer
patients 53 61 1124 1132 O
with 62 66 1133 1137 O
airway 67 73 1138 1144 O
tumor 74 79 1145 1150 B-cancer
recurrence 80 90 1151 1161 O
that 91 95 1162 1166 O
may 96 99 1167 1170 O
compromise 100 110 1171 1181 O
breathing 111 120 1182 1191 O
or 121 123 1192 1194 O
swallowing 124 134 1195 1205 O
if 135 137 1206 1208 O
inflammation 138 150 1209 1221 O
or 151 153 1222 1224 O
edema 154 159 1225 1230 B-chronic_disease
is 160 162 1231 1233 O
transiently 163 174 1234 1245 O
aggravated 175 185 1246 1256 O
by 186 188 1257 1259 O
Hiltonol 189 197 1260 1268 O
injection 198 207 1269 1278 O

Life 0 4 1279 1283 B-clinical_variable
expectancy 5 15 1284 1294 I-clinical_variable
of 16 18 1295 1297 O
less 19 23 1298 1302 O
than 24 28 1303 1307 O
6 29 30 1308 1309 B-upper_bound
months 31 37 1310 1316 I-upper_bound
in 38 40 1317 1319 O
the 41 44 1320 1323 O
judgment 45 53 1324 1332 O
of 54 56 1333 1335 O
the 57 60 1336 1339 O
study 61 66 1340 1345 O
physician 67 76 1346 1355 O

Melanoma 0 8 1356 1364 B-cancer

Non 0 3 1365 1368 B-cancer
- 3 4 1368 1369 I-cancer
Melanoma 4 12 1369 1377 I-cancer
skin 13 17 1378 1382 I-cancer
cancers 18 25 1383 1390 I-cancer

Patients 0 8 1391 1399 O
on 9 11 1400 1402 O
anticoagulation 12 27 1403 1418 B-treatment
therapy 28 35 1419 1426 I-treatment
with 36 40 1427 1431 O
an 41 43 1432 1434 O
INR>2 44 49 1435 1440 B-clinical_variable
may 50 53 1441 1444 O
be 54 56 1445 1447 O
enrolled 57 65 1448 1456 O
at 66 68 1457 1459 O
the 69 72 1460 1463 O
discretion 73 83 1464 1474 O
of 84 86 1475 1477 O
the 87 90 1478 1481 O
investigator 91 103 1482 1494 O
if 104 106 1495 1497 O
they 107 111 1498 1502 O
have 112 116 1503 1507 O
not 117 120 1508 1511 O
had 121 124 1512 1515 O
any 125 128 1516 1519 O
episodes 129 137 1520 1528 O
of 138 140 1529 1531 O
severe 141 147 1532 1538 O
hemorrhage 148 158 1539 1549 B-chronic_disease
and 159 162 1550 1553 O
if 163 165 1554 1556 O
the 166 169 1557 1560 O
site 170 174 1561 1565 O
to 175 177 1566 1568 O
be 178 180 1569 1571 O
injected 181 189 1572 1580 O
is 190 192 1581 1583 O
not 193 196 1584 1587 O
located 197 204 1588 1595 O
in 205 207 1596 1598 O
the 208 211 1599 1602 O
oropharynx 212 222 1603 1613 O
or 223 225 1614 1616 O
another 226 233 1617 1624 O
area 234 238 1625 1629 O
where 239 244 1630 1635 O
achieving 245 254 1636 1645 O
homeostasis 255 266 1646 1657 O
would 267 272 1658 1663 O
be 273 275 1664 1666 O
complicated 276 287 1667 1678 O
by 288 290 1679 1681 O
local 291 296 1682 1687 O
anatomy 297 304 1688 1695 O

Patients 0 8 1696 1704 O
with 9 13 1705 1709 O
resectable 14 24 1710 1720 B-chronic_disease
disease 25 32 1721 1728 I-chronic_disease
may 33 36 1729 1732 O
be 37 39 1733 1735 O
enrolled 40 48 1736 1744 O
after 49 54 1745 1750 O
having 55 61 1751 1757 O
refused 62 69 1758 1765 O
surgery 70 77 1766 1773 B-treatment
after 78 83 1774 1779 O
a 84 85 1780 1781 O
documented 86 96 1782 1792 O
consultation 97 109 1793 1805 O
with 110 114 1806 1810 O
a 115 116 1811 1812 O
surgeon 117 124 1813 1820 O

Persistent 0 10 1821 1831 O
toxicity 11 19 1832 1840 O
from 20 24 1841 1845 O
recent 25 31 1846 1852 B-treatment
therapy 32 39 1853 1860 I-treatment
that 40 44 1861 1865 O
has 45 48 1866 1869 O
not 49 52 1870 1873 O
sufficiently 53 65 1874 1886 O
resolved 66 74 1887 1895 O
in 75 77 1896 1898 O
the 78 81 1899 1902 O
judgment 82 90 1903 1911 O
of 91 93 1912 1914 O
the 94 97 1915 1918 O
study 98 103 1919 1924 O
physician 104 113 1925 1934 O

Platelets 0 9 1935 1944 B-clinical_variable
> 10 11 1945 1946 O
50,000 12 18 1947 1953 B-lower_bound
/ 18 19 1953 1954 I-lower_bound
mm3 19 22 1954 1957 I-lower_bound

Radiologically 0 14 1958 1972 O
or 15 17 1973 1975 O
visually 18 26 1976 1984 O
measurable 27 37 1985 1995 O
recurrent 38 47 1996 2005 O
or 48 50 2006 2008 O
metastatic 51 61 2009 2019 B-cancer
disease 62 69 2020 2027 I-cancer
that 70 74 2028 2032 O
is 75 77 2033 2035 O
measurable 78 88 2036 2046 O
and 89 92 2047 2050 O
at 93 95 2051 2053 O
least 96 101 2054 2059 O
10 102 104 2060 2062 B-lower_bound
mm 104 106 2062 2064 I-lower_bound
in 107 109 2065 2067 O
longest 110 117 2068 2075 O
dimension 118 127 2076 2085 O

Sarcoma 0 7 2086 2093 B-cancer

Sarcoma 0 7 2094 2101 B-cancer
Patients 8 16 2102 2110 O
must 17 21 2111 2115 O
be 22 24 2116 2118 O
14 25 27 2119 2121 B-lower_bound
years 28 33 2122 2127 I-lower_bound
of 34 36 2128 2130 O
age 37 40 2131 2134 B-age
or 41 43 2135 2137 O
older 44 49 2138 2143 O

Serious 0 7 2144 2151 O
concurrent 8 18 2152 2162 O
infection 19 28 2163 2172 O
or 29 31 2173 2175 O
medical 32 39 2176 2183 O
illness 40 47 2184 2191 O
, 47 48 2191 2192 O
which 49 54 2193 2198 O
would 55 60 2199 2204 O
jeopardize 61 71 2205 2215 O
the 72 75 2216 2219 O
ability 76 83 2220 2227 O
of 84 86 2228 2230 O
the 87 90 2231 2234 O
patient 91 98 2235 2242 O
to 99 101 2243 2245 O
receive 102 109 2246 2253 O
the 110 113 2254 2257 O
treatment 114 123 2258 2267 B-treatment
outlined 124 132 2268 2276 O
in 133 135 2277 2279 O
this 136 140 2280 2284 O
protocol 141 149 2285 2293 O
with 150 154 2294 2298 O
reasonable 155 165 2299 2309 O
safety 166 172 2310 2316 O

Squamous 0 8 2317 2325 B-cancer
head 9 13 2326 2330 I-cancer

This 0 4 2331 2335 O
lesion 5 11 2336 2342 O
can 12 15 2343 2346 O
be 16 18 2347 2349 O
superficial 19 30 2350 2361 O
cutaneous 31 40 2362 2371 O
, 40 41 2371 2372 O
subcutaneous 42 54 2373 2385 O
or 55 57 2386 2388 O
within 58 64 2389 2395 O
a 65 66 2396 2397 O
readily 67 74 2398 2405 O
accessible 75 85 2406 2416 O
lymph 86 91 2417 2422 O
node 92 96 2423 2427 O
and 97 100 2428 2431 O
must 101 105 2432 2436 O
measure 106 113 2437 2444 O
at 114 116 2445 2447 O
least 117 122 2448 2453 O
10 123 125 2454 2456 B-lower_bound
mm 126 128 2457 2459 I-lower_bound
in 129 131 2460 2462 O
longest 132 139 2463 2470 O
dimension 140 149 2471 2480 O

Total 0 5 2481 2486 B-clinical_variable
bilirubin 6 15 2487 2496 I-clinical_variable
≤ 16 17 2497 2498 O
1.5mg 18 23 2499 2504 B-upper_bound
/ 23 24 2504 2505 I-upper_bound
dl 24 26 2505 2507 I-upper_bound

Transaminases 0 13 2508 2521 B-clinical_variable
≤ 14 15 2522 2523 O
2 16 17 2524 2525 B-upper_bound
times 18 23 2526 2531 I-upper_bound
above 24 29 2532 2537 I-upper_bound
the 30 33 2538 2541 I-upper_bound
upper 34 39 2542 2547 I-upper_bound
limits 40 46 2548 2554 I-upper_bound
of 47 49 2555 2557 I-upper_bound
the 50 53 2558 2561 I-upper_bound
institutional 54 67 2562 2575 I-upper_bound
normal 68 74 2576 2582 I-upper_bound
, 74 75 2582 2583 O
- 76 77 2584 2585 O
INR<2 78 83 2586 2591 B-clinical_variable
( 84 85 2592 2593 O
international 85 98 2593 2606 O
normalized 99 109 2607 2617 O
ratio 110 115 2618 2623 O
) 115 116 2623 2624 O
if 117 119 2625 2627 O
off 120 123 2628 2631 O
of 124 126 2632 2634 O
anticoagulation 127 142 2635 2650 B-treatment

Unresectable 0 12 2651 2663 B-cancer
disease 13 20 2664 2671 I-cancer

While 0 5 2672 2677 O
animal 6 12 2678 2684 O
reproductive 13 25 2685 2697 O
studies 26 33 2698 2705 O
have 34 38 2706 2710 O
been 39 43 2711 2715 O
negative 44 52 2716 2724 O
, 52 53 2724 2725 O
the 54 57 2726 2729 O
simulated 58 67 2730 2739 O
viral 68 73 2740 2745 B-chronic_disease
infection 74 83 2746 2755 I-chronic_disease
and 84 87 2756 2759 O
anti 88 92 2760 2764 O
- 92 93 2764 2765 O
proliferative 93 106 2765 2778 O
activity 107 115 2779 2787 O
of 116 118 2788 2790 O
this 119 123 2791 2795 O
experimental 124 136 2796 2808 O
drug 137 141 2809 2813 O
may 142 145 2814 2817 O
theoretically 146 159 2818 2831 O
affect 160 166 2832 2838 O
the 167 170 2839 2842 O
developing 171 181 2843 2853 O
fetus 182 187 2854 2859 O
or 188 190 2860 2862 O
nursing 191 198 2863 2870 O
infant 199 205 2871 2877 O

Women 0 5 2878 2883 B-gender
of 6 8 2884 2886 O
childbearing 9 21 2887 2899 O
potential 22 31 2900 2909 O
must 32 36 2910 2914 O
have 37 41 2915 2919 O
a 42 43 2920 2921 O
negative 44 52 2922 2930 B-pregnancy
pregnancy 53 62 2931 2940 I-pregnancy
test 63 67 2941 2945 O

atients 0 7 2946 2953 O
with 8 12 2954 2958 O
the 13 16 2959 2962 O
potential 17 26 2963 2972 O
for 27 30 2973 2976 O
pregnancy 31 40 2977 2986 B-pregnancy
or 41 43 2987 2989 O
impregnating 44 56 2990 3002 O
their 57 62 3003 3008 O
partner 63 70 3009 3016 O
must 71 75 3017 3021 O
agree 76 81 3022 3027 B-contraception_consent
to 82 84 3028 3030 I-contraception_consent
follow 85 91 3031 3037 I-contraception_consent
acceptable 92 102 3038 3048 I-contraception_consent
birth 103 108 3049 3054 I-contraception_consent
control 109 116 3055 3062 I-contraception_consent
methods 117 124 3063 3070 I-contraception_consent
to 125 127 3071 3073 O
avoid 128 133 3074 3079 O
conception 134 144 3080 3090 B-contraception_consent

neck 0 4 3091 3095 B-cancer
cancer 5 11 3096 3102 I-cancer

